Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Adenocarcinoma × tepotinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma 1

Interventions

zolbetuximab 2 Oxaliplatin 2 Afatinib 2 trastuzumab deruxtecan 1 tepotinib 1 repotrectinib 1 pralsetinib 1 brigatinib 1 Standard of Care 1 Pemetrexed 1 Leucovorin 1 Fluorouracil 1 Crizotinib 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02864992 2025-12-23

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

EMD Serono

Phase 2 Active not recruiting

337 enrolled 13 charts 2 FDA

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡